Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/7/04 → 8/10/10 |
Funding
- Covance Periapproval Services, Inc. (VX03-497-205 // VX03-497-205)
- Vertex Pharmaceuticals Incorporated (VX03-497-205 // VX03-497-205)
Prot# VX03-497-205: A Phase 2b Study of Merimepodib in Combination with Pegylated Interferon Alfa-2a (Pegasys®) and Ribavirin in Subjects with Chronic Genotype 1 Hepatitis C Non-Responsive to Prior Therapy with Pegylated Interferon Alfa and Ribavirin
- Flamm, Steven L (PD/PI)
Project: Research project